Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   

Parkinson’s Disease Dementia

chronic traumatic encephalopathy1 - alzheimer's-related plaque1 - preventing alzheimer's1 - voxel-based morphometry1 - elderly people1 - low-density lipoprotein receptor-related protein 61 - exercise games1 - alzheimer's plan1 - rheumatoid arthritis1 - apoe-e4 gene1 - ssri2 - apoe genotype1 - alzheimer's and parkinson's diseases1 - immune globulin1 - amyloid beta peptide1 - alzheimer's disease risk3 - poor sleep1 - microrna1 - heart disease8 - alzheimer's disease biomarkers1 - behaviours redolent1 - senility1 - risk for dementia1 - development of parkinson's1 - reverse cholesterol transport1 - short-term memory problems1 - cognitive enhancement1 - motor development1 - learning1 - hip fracture1 -